Nephrotic syndrome: vizsgálatok itt: Németország
5 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Where
- Berlin, Dresden, Hanover
- Életkor
- 16 év to 75 év
- People
- 84 worldwide
- Run by
- Sanofi
See details and how to joinNCT06500702 - 2. fázisNot yet taking people in NémetországA Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)
- Where
- Stuttgart
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Medical University Innsbruck
See details and how to joinNCT07710157 - 2. fázisTaking peopleStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Where
- Cologne, Hamburg, Heidelberg
- Életkor
- 1 év to 17 év
- People
- 67 worldwide
- Run by
- Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00 - No phaseNot yet taking people in NémetországSLIT ABS: Study on Patients With Autoimmune Podocytopathy
- Where
- München
- Életkor
- 0 év to 99 év
- People
- 50 worldwide
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07516964 - No phaseTaking peopleThe FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
- Where
- Aachen, Berlin, Bonn, Cologne, Dachau, Erlangen, Essen, Heidelberg, Leipzig, Marburg, Münster, Stuttgart
- People
- 500
- Run by
- Prof. Dr. Paul Brinkkoetter
See details and how to joinNCT03949972